As part of a new attempt to resolve tens of thousands of talcum powder cancer lawsuits for about $8 billion, Johnson & Johnson has initiated a third bankruptcy filing, this time involving its subsidiary Red River Talc.
A Mounjaro lawsuit claims Eli Lilly failed to warn patients that gastroparesis side effects could result in cyclical vomiting lasting more than a year.
Federal judge has ordered plaintiffs to propose a single talcum powder cancer lawsuit for the first federal bellwether trial, which is scheduled to begin in December.